Medgenome Labs

Login to claim this Startup
MedGenome's state-of-the-art NGS platforms generate high quality sequencing data from gene panels, exomes, whole genomes and transcriptomes. The nimble and powerful NGS-LIMS system provides an integrated tracking, analysis and data reporting environment ensuring accuracy, consistency and efficient turnaround time and makes the process highly cost effective. NGS data is analyzed using powerful proprietary data analysis software (VariMat) and variants are interpreted to establish clinical significance using a database of annotated variants curated from published literature (OncoMD). OncoMD is an interactive user interface that bridges the gap between clinical discovery and medical intervention by linking disease-specific variants to approved drugs and open clinical trials.

Owners
  1. Sam Santhosh
Venture Capitals
  1. Sequoia Capital